Daniel Jacoby, M.D.
Dr. Daniel Jacoby directs the Center for Advanced Heart Failure, and is the founder and Director of the Cardiomyopathy Program at Yale. He specializes in treatment of heart failure and inherited heart muscle disease (cardiomyopathy). Dr. Jacoby’s clinical and research programs are dedicated to serving the needs of patients, and families, living with the diagnosis of cardiomyopathy. Expert diagnosis and treatment of hypertrophic, dilated, arrhythmogenic and restrictive cardiomyopathies, as well as evaluation for causes of sudden cardiac death, are available through the Cardiomyopathy Program. Dr. Jacoby engages clinical evaluation, genetic analysis, novel treatments, clinical trials, and translational research to optimize care for his patients. Over the years he has developed considerable expertise in genotype-phenotype correlation. Genotype-phenotype correlation describes the relationship between the disease experienced by the patient, and the gene abnormality causing the disease. This relationship is often complex since the same gene expresses itself uniquely in each patient due to the influence of other genes and environmental factors. Interpreting gene test results, and incorporating that information into specialized clinical care for unique cardiac conditions is a core mission for Dr. Jacoby’s programs. Dr. Jacoby also runs the heart transplant, mechanical circulatory support, and general heart failure programs for the Yale School of Medicine and Yale New Haven Hospital. Treating patients with end-stage heart failure, and improving systems management for patients living with heart failure in the general population are the core missions of this program. Ongoing initiatives include adoption of novel cutting edge technology, measuring and improving quality of life for patients, improving appropriate access to palliative care services, and educating providers throughout the Yale New Haven Health System on best practices. Dr. Jacoby received his MD at the Yale School of Medicine, was a Fellow at Columbia Presbyterian Hospital, completed his residency at Mount Sinai Hospital and holds Board Certifications by the American Board of Internal Medicine, Cardiovascular Disease, the National Board of Echocardiography, Adult Echocardiography and the Board of Nuclear Cardiology.